Asthma

British Medical Journal

Volumn 334, Issue 7598, 2007, Pages 847-850

  Pinnock, Hilary ^a   Shah, Rupal ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Battersea Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST; ANTIASTHMATIC AGENT;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; HAY FEVER; HUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; CLINICAL COMPETENCE; PATIENT REFERRAL; REVIEW; STANDARD; TELECONSULTATION;

ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL COMPETENCE; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; REFERRAL AND CONSULTATION; REMOTE CONSULTATION; RHINITIS;

EID: 34247645422     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39140.634896.BE     Document Type: Article

References (12)

1. Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, et al. Accessibility, acceptability, and effectiveness of telephone reviews for asthma in primary care: randomised controlled trial. BMJ 2003;326:477-9.
2. Gruffydd-Jones K, Hollinghurst S, Ward S, Taylor G. Targeted routine asthma care in general practice using telephone triage. Br J Gen Pract 2005;55:918-23.
3. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, et al for the National Heart, Lung, and Blood Institute's Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519-28.
4. Walker S, Sheikh A. Self reported rhinitis is a significant problem for patients with asthma. Prim Care Respir J 2005;14:83-7.
5. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; the SMART Study Group. The salmeterol multicenter asthma research trial. A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26.
6. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144:904-12.
7. Tomerak AA, Vyas H, Lakenpaul M, McGlashan JJ, McKean M. Inhaled beta2-agonists for treating non-specific chronic cough in children. Cochrane Database Sysr Rev 2005;(3):CD005373.
8. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guidelines on the management of asthma. A national clinical guideline. London: BTS, SIGN, 2003 [updated 2005]. (Available from www.brit-thoracic.org.uk and at www.sign.ac.uk.)
9. Foresi A, Morelli MC, Catena E, for the Italian Study Group. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest 2000;117:440-6.
10. Cochran D. Diagnosing and treating chesty infants. BMJ 1998;316:1546-7.
11. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax 2004;59:94-9.
12. Campbell MJ, Holgate ST, Johnson SL. Trends in asthma mortality. BMJ 1997;314:1439-41.